In this webinar, David Chrimes, PhD discusses the frequency of aneuploidy in miscarriage, particularly in relation to maternal age, and shares evidence for utilization of PGT-A for miscarriage reduction.
Contributors

David Chrimes PhD
Director of Global Genomics Business Development, CooperSurgical